Experts in Prescription Drug Withdrawal
An affordable tapering program to help you taper off Pristiq
Pristiq (Desvenlafaxine) is the active metabolite of Effexor (Venlafaxine) and was approved in January 2007. While Pristiq was approved in both the United States and Canada, the European Union declined the status, stating in part that Pristiq (marketed under the name Ellefore in Europe) "the Committee for Medicinal Products for Human Use had some concerns and was of the provisional opinion that Ellefore could not have been approved for the treatment of major depressive disorder [and] overall, the effectiveness of Ellefore had not been shown convincingly. In relation to its parent substance, Venlafaxine, Desvenlafaxine seemed to be less effective with no advantages in terms of safety and tolerability." Wyeth subsequently withdrew its application for approval.
Pristiq has also shown higher rates of discontinuation syndrome (withdrawals) than other SSRI or SNRI antidepressants. The symptoms can be severe and considered “intolerable” by many patients and therefore the need to gradually taper is highly recommended.
Our nonprofit team are experts at Pristiq Withdrawals. Learn how to naturally minimize Pristiq withdrawal symptoms while gently tapering.
How Our Pristiq Withdrawal Program Works:
- Our nonprofit team has recovered and guides you throughout the Prisiq taper process.
- Our private discussion board is available 24/7 for support.
- Calming Nutraceuticals are used daily to help minimize Pristiq withdrawal symptoms.
- Interaction items are eliminated to help your Pristiq Withdrawal be more comfortable.
- No addictive medications are added. Instead we take an all-natural approach to reduce the symptoms from Pristiq Withdrawal.
- We provide your physician with tapering recommendations to slowly titrate.
- Our experts teach you how to address symptoms naturally.
- Don't let Pristiq interrupt your life. Begin our program now.
Call toll free 866.605.2333 for a free consultation or send us a confidential inquiry.
*nutraceuticals are used throughout the taper
Other Withdrawal Programs
Pristiq side effects may include:
allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives), irregular heartbeat or pulse, low blood pressure (dizziness, weakness), high blood pressure (severe headache, blurred vision), chills or fever, unusual bleeding or bruising, rash or hives, Suicidal Ideation, Headache, tremor, nervousness, or anxiety; difficulty concentrating, constipation, nausea, diarrhea, dry mouth, or changes in appetite or weight, weakness, increased sweating, sleeping or insomnia, decreased sex drive, impotence, or difficulty having an orgasm
Pristiq Withdrawal Symptoms May Include:
aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathisia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech or visual changes, worsened depression
What is Pristiq?
Pristiq (Desvenlafaxine) is an antidepressant of the Serotonin Norepinephrine Reuptake Inhibitor class and is the synthetic form of the major active metabolite of Effexor (Venlafaxine), and is being targeted as the first non-hormonal treatment for menopause. Effexor lost its patent protection in August 2006 and Pristiq was approved In January 2007. In the European Union, Desvenlafaxine has not been approved for any use. The Committee for Medicinal Products for Human Use stated the effectiveness had not been shown convincingly. Pristiq has higher rates of withdrawals (discontinuation syndrome) than other SSRI and SNRI antidepressant medications due to its relatively short half-life. The manufacturer states that discontinuation symptoms may occur, especially when therapy is stopped suddenly.
Click here for more information on antidepressants...
People We've Helped
"I've returned to my life but it's better than it was before because I have such gratitude and appreciation for all that I have. Many thanks."
-Suzy L., (Canada) Pristiq
Frequently Asked Questions: Answers to commonly asked questions. MORE...